| __timestamp | ACADIA Pharmaceuticals Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 72471000 |
| Thursday, January 1, 2015 | 90804000 | 89204000 |
| Friday, January 1, 2016 | 186456000 | 106010000 |
| Sunday, January 1, 2017 | 255062000 | 137905000 |
| Monday, January 1, 2018 | 265758000 | 159888000 |
| Tuesday, January 1, 2019 | 325638000 | 158425000 |
| Wednesday, January 1, 2020 | 388661000 | 200677000 |
| Friday, January 1, 2021 | 396028000 | 304759000 |
| Saturday, January 1, 2022 | 369090000 | 377221000 |
| Sunday, January 1, 2023 | 402466000 | 336361000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A expenses of ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, ACADIA's SG&A expenses surged by over 1,100%, reflecting its aggressive expansion and marketing strategies. In contrast, Supernus Pharmaceuticals saw a more modest increase of around 360%, indicating a more conservative approach.
By 2023, ACADIA's expenses peaked at approximately 402 million, while Supernus reached about 336 million. This divergence highlights differing strategic priorities, with ACADIA focusing on rapid growth and Supernus on steady, sustainable development. Understanding these trends offers valuable insights into each company's operational focus and market positioning.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or ACADIA Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights